Royalty Pharma (RPRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Royalty Pharma

    NASDAQ: RPRX · Real-Time Price · USD
    35.04
    0.14 (0.40%)
    At close: Sep 26, 2025, 3:59 PM
    34.88
    -0.46%
    After-hours: Sep 26, 2025, 07:40 PM EDT

    Royalty Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 929.03M 477.01M 1.71B 1.54B
    Short-Term Investments
    		 841.97M 756.74M 717.04M 1.26B
    Long-Term Investments
    		 16.39B 15.1B 14.23B 14.63B
    Other Long-Term Assets
    		 33.53M 6.52M 29.63M 4.14M
    Receivables
    		 26.96M 22.41M 36.6M 68.31M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 4.19M 18.04M 90.52M 6.63M
    Total Current Assets
    		 1.8B 1.27B 2.55B 2.88B
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a 5.67M
    Total Long-Term Assets
    		 16.42B 15.11B 14.26B 14.64B
    Total Assets
    		 18.22B 16.38B 16.81B 17.52B
    Account Payables
    		 13.37M 15.16M 7.91M 5.62M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 997.77M n/a 997.51M n/a
    Other Current Liabilities
    		 68.6M 11.38M 12.4M n/a
    Total Current Liabilities
    		 1.25B 161.38M 1.17B 171.25M
    Long-Term Debt
    		 6.61B 6.14B 6.12B 7.1B
    Other Long-Term Liabilities
    		 12.08M 900K 2.5M n/a
    Total Long-Term Liabilities
    		 6.63B 6.14B 6.12B 7.1B
    Total Liabilities
    		 7.88B 6.3B 7.29B 7.27B
    Total Debt
    		 7.61B 6.14B 7.12B 7.1B
    Book Value
    		 10.34B 10.08B 9.53B 10.25B
    Book Value Per Share
    		 23.19 22.53 21.75 24.71
    Common Stock
    		 108K 108K 107K 106K
    Retained Earnings
    		 2.85B 2.52B 1.96B 2.26B
    Comprehensive Income
    		 n/a n/a n/a 16.49M
    Shareholders Equity
    		 6.95B 6.53B 5.63B 5.78B
    Total Investments
    		 17.23B 15.86B 14.95B 15.89B

    Add to Watchlist